Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Verotoxigenic Escherichia coli: costs of illness in Canada, including long-term health outcomes.

Sockett P, Goebel SE, Varela NP, Guthrie A, Wilson J, Guilbault LA, Clark WF.

J Food Prot. 2014 Feb;77(2):216-26. doi: 10.4315/0362-028X.JFP-13-177.

PMID:
24490915
[PubMed - in process]
2.

Cost of illness and disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.

Tariq L, Haagsma J, Havelaar A.

J Food Prot. 2011 Apr;74(4):545-52. doi: 10.4315/0362-028X.JFP-10-252.

PMID:
21477467
[PubMed - indexed for MEDLINE]
3.

Economic cost of illness due to Escherichia coli O157 infections in the United States.

Frenzen PD, Drake A, Angulo FJ; Emerging Infections Program FoodNet Working Group.

J Food Prot. 2005 Dec;68(12):2623-30.

PMID:
16355834
[PubMed - indexed for MEDLINE]
4.

Estimated Numbers of Community Cases of Illness Due to Salmonella, Campylobacter and Verotoxigenic Escherichia Coli: Pathogen-specific Community Rates.

Thomas MK, Majowicz SE, Sockett PN, Fazil A, Pollari F, Doré K, Flint JA, Edge VL.

Can J Infect Dis Med Microbiol. 2006 Jul;17(4):229-34.

PMID:
18382633
[PubMed]
Free PMC Article
5.

Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(26):1-50. Epub 2009 Nov 1.

PMID:
23074531
[PubMed]
Free PMC Article
6.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
[PubMed - indexed for MEDLINE]
7.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
[PubMed - indexed for MEDLINE]
8.

Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada.

Woodward DL, Clark CG, Caldeira RA, Ahmed R, Rodgers FG.

Can J Infect Dis. 2002 Sep;13(5):321-30.

PMID:
18159408
[PubMed]
Free PMC Article
9.

Methods for the detection and isolation of Shiga toxin-producing Escherichia coli.

De Boer E, Heuvelink AE.

Symp Ser Soc Appl Microbiol. 2000;(29):133S-143S. Review.

PMID:
10880188
[PubMed - indexed for MEDLINE]
10.

Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1.

PMID:
23074461
[PubMed]
Free PMC Article
11.

[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].

Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E.

Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Italian.

PMID:
23435779
[PubMed - indexed for MEDLINE]
12.

[Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].

Wolfenstetter SB.

Gesundheitswesen. 2006 Oct;68(10):600-12. German.

PMID:
17099820
[PubMed - indexed for MEDLINE]
13.

Hyperbaric oxygen therapy for non-healing ulcers in diabetes mellitus: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(11):1-28. Epub 2005 Sep 1.

PMID:
23074462
[PubMed]
Free PMC Article
14.

Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jun 10;60(22):749-55.

PMID:
21659984
[PubMed - indexed for MEDLINE]
Free Article
15.

Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.

McCarthy TA, Barrett NL, Hadler JL, Salsbury B, Howard RT, Dingman DW, Brinkman CD, Bibb WF, Cartter ML.

Pediatrics. 2001 Oct;108(4):E59.

PMID:
11581467
[PubMed - indexed for MEDLINE]
16.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

PMID:
23146319
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Economic costs of Shiga toxin-producing Escherichia coli infection in Australia.

McPherson M, Kirk MD, Raupach J, Combs B, Butler JR.

Foodborne Pathog Dis. 2011 Jan;8(1):55-62. doi: 10.1089/fpd.2010.0608. Epub 2010 Nov 17.

PMID:
21083512
[PubMed - indexed for MEDLINE]
18.

Prevalence of Escherichia coli O-types and Shiga toxin genes in fecal samples from feedlot cattle.

Dargatz DA, Bai J, Lubbers BV, Kopral CA, An B, Anderson GA.

Foodborne Pathog Dis. 2013 Apr;10(4):392-6. doi: 10.1089/fpd.2012.1289. Epub 2013 Mar 4.

PMID:
23458025
[PubMed - indexed for MEDLINE]
19.

Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet).

Clogher P, Hurd S, Hoefer D, Hadler JL, Pasutti L, Cosgrove S, Segler S, Tobin-D'Angelo M, Nicholson C, Booth H, Garman K, Mody RK, Gould LH.

Clin Infect Dis. 2012 Jun;54 Suppl 5:S446-52. doi: 10.1093/cid/cis246.

PMID:
22572668
[PubMed - indexed for MEDLINE]
Free Article
20.

Streamlined analysis for evaluating the use of preharvest interventions intended to prevent Escherichia coli O157:H7 illness in humans.

Withee J, Williams M, Disney T, Schlosser W, Bauer N, Ebel E.

Foodborne Pathog Dis. 2009 Sep;6(7):817-25. doi: 10.1089/fpd.2008.0255.

PMID:
19737060
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk